Bringing the fundamentals into focus…
Back to BioMarin Pharmaceutical Inc.
How BioMarin Pharmaceutical Inc. stacks up
BMRN · against 147 other Healthcare companies of similar size
Growth
37/ 100
Near the bottom of its peers.
Ranked #119 of 148 · scores higher than 18% of peers
Bars: peers in each 10-point band of the growth score20 peers with a growth score of 30–39, including BMRN · Click a bar to see the companies
Why growth scores 37?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth, which is weaker than most Healthcare peers.
- slower growth in earnings per share: weaker than 98% of peers. Earnings per share growth: -89.0% vs peer median 9.8%
- faster revenue growth over the last year: stronger than 64% of peers. Revenue growth: 11.2% vs peer median 6.1%
- faster revenue growth over three years: stronger than 74% of peers. 3-year revenue growth: 15.1% vs peer median 5.8%
Metric by metric
Position: dot = BMRN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BMRN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 149 reported | 11.2% | 10.2% | 53% | 33% | |
| Earnings per share growthHigher is better · 108 reported | -89.0% | 14.1% | 3% | 33% | |
| 3-year revenue growthHigher is better · 143 reported | 15.1% | 10.9% | 67% | 33% |
Ranking by growth score
Top 5 and the companies ranked around BMRN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 21.4B USD | 97 | 67 | |
| 3 | 7.3B USD | 97 | 74 | |
| 115 | 593.2B INR (≈$7.1B) | 38 | 47 | |
| 115 | 16.1B CHF (≈$18.5B) | 38 | 54 | |
| 119 | 49.0B CNY (≈$6.9B) | 37 | 60 | |
| 119 | 11.2B EUR (≈$12.3B) | 37 | 63 | |
| 119 | 10.8B USD | 37 | 41 | |
| 119 | 8.5B USD | 37 | 28 | |
| 123 | 5.9B USD | 36 | 39 | |
| 124 | 1.42T JPY (≈$9.6B) | 34 | 50 | |
| 125 | 13.2B USD | 33 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score